Combination of transcriptomic and proteomic approaches helps unravel the mechanisms of luteolin in inducing liver cancer cell death via targeting AKT1 and SRC

• المؤلفون الرئيسيون: Junxia Ma (مؤلف), Jinggang Mo (مؤلف), Yifu Feng (مؤلف), Liezhi Wang (مؤلف), Hao Jiang (مؤلف), Junmin Li (مؤلف), Chong Jin (مؤلف)
• التنسيق: كتاب
• منشور في: Frontiers Media S.A., 2024-08-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

IntroductionLuteolin, a natural compound commonly used in traditional Chinese medicine, shows clinical potential as an anti-liver cancer agent. The mechanisms underlying the anti-liver cancer effect of luteolin are limited versus those reported for other cancers. Accordingly, this study was conducte...